H-FLLTRILTI-OH

Ref. 3D-PP41800

Produktinformation

• Name: H-FLLTRILTI-OH

Beschreibung

Peptide H-FLLTRILTI-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-FLLTRILTI-OH include the following: Nonstimulatory peptide-MHC enhances human T-cell antigen-specific responses by amplifying proximal TCR signaling X Zhao , S Sankaran, J Yap, CT Too, ZZ Ho - Nature , 2018 - nature.comhttps://www.nature.com/articles/s41467-018-05288-0 Blockade of Tim-3 signaling restores the virus-specific CD8+ T-cell response in patients with chronic hepatitis B W Wu, Y Shi , S Li , Y Zhang, Y Liu - European journal of , 2012 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.201141852 In vivo hierarchy of immunodominant and subdominant HLA-A* 0201-restricted T-cell epitopes of HBx antigen of hepatitis B virus S Malmassari, YC Lone, M Zhang, C Transy - Microbes and , 2005 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1286457905000456 Using structural analysis to explore the role of hepatitis B virus mutations in immune escape from liver cancer in Chinese, European and American populations S Gu, L Lv, X Lin, X Li, J Dai, J Zhang - Journal of , 2022 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/07391102.2020.1830852 Modulation of the CD8+-T-Cell Response by CD4+ CD25+ Regulatory T Cells in Patients with Hepatitis B Virus Infection O Franzese, PTF Kennedy, AJ Gehring , J Gotto - Journal of , 2005 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.79.6.3322-3328.2005 Proteogenomic identification of Hepatitis B virus (HBV) genotype-specific HLA-I restricted peptides from HBV-positive patient liver tissues M Srivastava, R Copin , A Choy, A Zhou - Frontiers in , 2022 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2022.1032716/full Targeting hepatitis B virus-infected cells with a T-cell receptor-like antibody KSR Sastry , CT Too, K Kaur, AJ Gehring , L Low - Journal of , 2011 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/JVI.01990-10 P73. Functional characterisation of HBV-specific T cell receptors for redirection of T cells against HBV infected hepatocytes K Krebs, K Metzger, L Weigand, C Dargel - for ImmunoTherapy of , 2014 - Springerhttps://link.springer.com/article/10.1186/2051-1426-2-S2-P47 Human MAIT cells endowed with HBV specificity are cytotoxic and migrate towards HBV-HCC while retaining antimicrobial functions K Healy , A Pavesi , T Parrot, MJ Sobkowiak - JHEP Reports, 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S258955592100094X Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infection J Kah, S Koh, T Volz, E Ceccarello - The Journal of , 2017 - Am Soc Clin Investighttps://www.jci.org/articles/view/93024 Expression of CD3+ CD8+ human leukocyte antigen-A2+ T lymphocytes with specificity to the different hepatitis B virus peptides in patients with hepatitis B associated J Cheng, L Wang, C Qiu, Y AI, J LU - Chinese Journal of , 2012 - pesquisa.bvsalud.orghttps://pesquisa.bvsalud.org/portal/resource/pt/wpr-425747 A mutant HBs antigen (HBsAg) 183-191 epitope elicits specific cytotoxic T lymphocytes in acute hepatitis B patients HG Liu, ZP Fan, WW Chen, HY Yang - Clinical & , 2008 - academic.oup.comhttps://academic.oup.com/cei/article-abstract/151/3/441/6494732 Expression of LAG-3 is coincident with the impaired effector function of HBV-specific CD8+ T cell in HCC patients FJ Li, Y Zhang, GX Jin, L Yao, DQ Wu - Immunology letters, 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0165247812002507 Proliferation and Function of CD4+ and T Cells from Chronic Hepatitis B Patients E Sripariwuth, S Pongcharoen - Siriraj Medical Journal, 2014 - med.nu.ac.thhttp://www.med.nu.ac.th/dpMed/fileResearch/9_research_ekaweemed.pdf Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection C Boni, P Fisicaro , C Valdatta, B Amadei - Journal of , 2007 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.02844-06 T cell inflammation profile after surgical resection may predict tumor recurrence in HBV-related hepatocellular carcinoma B Song, S Zhen, F Meng - International immunopharmacology, 2016 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1567576916304209 A 3D microfluidic model for preclinical evaluation of TCR-engineered T cells against solid tumors A Pavesi , AT Tan , S Koh, A Chia, M Colombo - JCI insight, 2017 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472441/

• Marke: Biosynth